ACADIA Pharmaceuticals Inc (DR6.BE)
Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
At close: 08:08AM CEST
| Previous Close | 15.68 |
| Open | 15.95 |
| Bid | 15.90 x 0 |
| Ask | 15.98 x 0 |
| Day's Range | 15.95 - 15.95 |
| 52 Week Range | 15.16 - 29.60 |
| Volume | |
| Avg. Volume | 7 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | May 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ZacksAcadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
Acadia (ACAD) delivered earnings and revenue surprises of 150% and 0.52%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Business WireAcadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
SAN DIEGO, May 08, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the first quarter ended March 31, 2024.
ZacksWatch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Let us look at five drug, generic companies, PRGO, IOVA, VTRS, TEVA and ACAD, which are gearing up for their earnings release this week.
© 2024 Yahoo. All rights reserved.